UBS Group’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Buy |
|
|||||
|
2025
Q1 | $840K | Buy |
|
|||||
|
2024
Q4 | $230K | Buy |
|
|||||
|
2024
Q3 | $148K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $265K | Buy |
|
|||||
|
2023
Q4 | $219K | Buy |
|
|||||
|
2023
Q3 | $84.4K | Sell |
|
|||||
|
2023
Q2 | $147K | Buy |
|
|||||
|
2023
Q1 | $95.1K | Buy |
|
|||||
|
2022
Q4 | $34.6K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $668K | Buy |
|
|||||
|
2022
Q1 | $888K | Sell |
|
|||||
|
2021
Q4 | $1.11M | Buy |
|
|||||
|
2021
Q3 | $57K | Sell |
|
|||||
|
2021
Q2 | $191K | Sell |
|
|||||
|
2021
Q1 | $1.08M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $64K | Sell |
|
|||||
|
2020
Q1 | $124K | Sell |
|
|||||
|
2019
Q4 | $445K | Buy |
|
|||||
|
2019
Q3 | $222K | Buy |
|
|||||
|
2019
Q2 | $270K | Buy |
|
|||||
|
2019
Q1 | $153K | Sell |
|
|||||
|
2018
Q4 | $1.6M | Buy |
|
|||||
|
2018
Q3 | $18K | Sell |
|
|||||
|
2018
Q2 | $50K | Sell |
|
|||||
|
2018
Q1 | $1.5M | Buy |
|
|||||
|
2017
Q4 | $794K | Buy |
|
|||||
|
2017
Q3 | $28K | Sell |
|
|||||
|
2017
Q2 | $277K | Buy |
|
|||||
|
2017
Q1 | $20K | Sell |
|
|||||
|
2016
Q4 | $17K | Buy |
|
|||||
|
2016
Q3 | $22K | Buy |
|
|||||
|
2016
Q2 | $1K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $8K | Buy |
|